Aethlon Medical skyrockets after merger with North Immunology
17/09/2026 12:28
BUZZ-Aethlon Medical skyrockets after merger with North Immunology ** Shares of medical device developer Aethlon Medical AEMD.O soar 430% to $7.58 premarket after co enters all-stock merger agreement with private biotech co North Immunology
** If gains hold, stock set to open at its highest since June 2026
** Combined company to operate as North Immunology and trade under ticker NRTX with a pro forma equity value of $346.5 mln
** AEMD shareholders are expected to own about 4.75% of combined co
** Deal includes a $180 mln private placement expected to fund the combined co's operations into H2 2028
** Through last close, AEMD was valued at $2.3 mln after losing about 90% YTD
(Reporting by Darshan Kumar in Bengaluru)
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology